Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Der Nervenarzt
|
March 20, 2015
[Is the use of placebo as control group in MS drug trials still appropriate?]
A Haghikia, R Gold
Der Nervenarzt
|
August 12, 2015
[Reply]
A Haghikia, R Gold
Der Nervenarzt
|
March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]
A Haghikia, R A Linker
Der Nervenarzt
|
March 27, 2014
[Fumaric acid as therapeutic agent for multiple sclerosis]
A Haghikia, R Linker, R Gold
Der Nervenarzt
|
April 26, 2008
[Open use of natalizumab. Neutralising antibodies and clinical data]
A Haghikia, M Fischer, K Hellwig, et al.
Acta Neurologica Scandinavica
|
January 22, 2008
Reproductive counselling, treatment and course of pregnancy in 73 German MS patients
K Hellwig, N Brune, A Haghikia, et al.
Multiple Sclerosis and Related Disorders
|
May 27, 2015
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry
B Bellenberg, R Schneider, F Weiler, et al.
Neurology
|
May 18, 2012
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A K Trampe, C Hemmelmann, A Stroet, et al.
Basic Research in Cardiology
|
July 2, 2013
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
A Haghikia, E Podewski, E Libhaber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2023
Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI)
A Brand, C Hornig, C Crayen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Der Nervenarzt
|
March 20, 2015
[Is the use of placebo as control group in MS drug trials still appropriate?]
A Haghikia, R Gold
Der Nervenarzt
|
August 12, 2015
[Reply]
A Haghikia, R Gold
Der Nervenarzt
|
March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]
A Haghikia, R A Linker
Der Nervenarzt
|
March 27, 2014
[Fumaric acid as therapeutic agent for multiple sclerosis]
A Haghikia, R Linker, R Gold
Der Nervenarzt
|
April 26, 2008
[Open use of natalizumab. Neutralising antibodies and clinical data]
A Haghikia, M Fischer, K Hellwig, et al.
Acta Neurologica Scandinavica
|
January 22, 2008
Reproductive counselling, treatment and course of pregnancy in 73 German MS patients
K Hellwig, N Brune, A Haghikia, et al.
Multiple Sclerosis and Related Disorders
|
May 27, 2015
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry
B Bellenberg, R Schneider, F Weiler, et al.
Neurology
|
May 18, 2012
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A K Trampe, C Hemmelmann, A Stroet, et al.
Basic Research in Cardiology
|
July 2, 2013
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
A Haghikia, E Podewski, E Libhaber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
December 20, 2023
Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI)
A Brand, C Hornig, C Crayen, et al.
Page
of 2